These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4114691)

  • 41. [THE USE OF ANTIBACILLARY DRUGS].
    BERNARD E; PIERON R
    Cah Coll Med Hop Paris; 1964 Apr; 5():241-51. PubMed ID: 14146836
    [No Abstract]   [Full Text] [Related]  

  • 42. [Morphological changes in the bronchi and lungs of healthy rats during prolonged inhalation of antibacterial compounds].
    Kulik NM; Nesterov EN
    Antibiotiki; 1971 Jun; 16(6):546-8. PubMed ID: 5112492
    [No Abstract]   [Full Text] [Related]  

  • 43. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 44. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 45. [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid].
    Uçak D; Uçak A
    Tip Fak Mecm; 1969; 32(1):48-52. PubMed ID: 5398987
    [No Abstract]   [Full Text] [Related]  

  • 46. Newer knowledge of chemotherapy in the treatment of tuberculosis of bones and joints.
    Friedman B; Kapur VN
    Clin Orthop Relat Res; 1973; (97):5-15. PubMed ID: 4359522
    [No Abstract]   [Full Text] [Related]  

  • 47. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of pulmonary tuberculosis.
    Byrd RB; Kaplan PD; Gracey DR
    Chest; 1974 Nov; 66(5):560-7. PubMed ID: 4139002
    [No Abstract]   [Full Text] [Related]  

  • 49. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
    Trnka L; Tousek J
    Chemotherapy; 1974; 20(3):165-76. PubMed ID: 4136827
    [No Abstract]   [Full Text] [Related]  

  • 50. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 51. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of tuberculosis today in Nebraska.
    Burgher LW; Kass I
    Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990
    [No Abstract]   [Full Text] [Related]  

  • 53. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 55. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 56. Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong.
    Tubercle; 1976 Jun; 57(2):81-95. PubMed ID: 134476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 58. [PULMONARY TUBERCULOSIS MISDIAGNOSED AS OTHER DISEASES].
    SUGIYAMA K
    Rinsho Hoshasen; 1963 Dec; 8():919-20. PubMed ID: 14101293
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurological manifestations and toxicities of the antituberculosis drugs. A review.
    Holdiness MR
    Med Toxicol; 1987; 2(1):33-51. PubMed ID: 3547005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The importance of medical treatment of pulmonary tuberculosis from a new viewpoint].
    HEYMER A
    Internist (Berl); 1962 Oct; 3():574-85. PubMed ID: 13954331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.